₹235.4*
MRP ₹261.5
10% off
₹222.27*
MRP ₹261.5
15% CB
₹39.23 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
निर्माता/विपणक :
अज़्का फार्मास्युटिकल्स प्राइवेट लिमिटेड
सेवन का प्रकार :
मौखिक
वापसी नीति :
वापसी योग्य नहीं
इसके बाद या उसके बाद समाप्त हो रहा है :
Jan-27
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Tellzy-CH 6.25 Tablet:
Co-administration of Aliskiren with Tellzy-CH 6.25 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Tellzy-CH 6.25 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Co-administration of Aliskiren with Tellzy-CH 6.25 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Tellzy-CH 6.25 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Critical
How does the drug interact with Tellzy-CH 6.25 Tablet:
Co-administration of Tellzy-CH 6.25 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Tellzy-CH 6.25 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Co-administration of Tellzy-CH 6.25 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Tellzy-CH 6.25 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Tellzy-CH 6.25 Tablet:
Coadministration of enalapril with Tellzy-CH 6.25 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Tellzy-CH 6.25 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of enalapril with Tellzy-CH 6.25 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Tellzy-CH 6.25 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Severe
How does the drug interact with Tellzy-CH 6.25 Tablet:
Taking ramipril with Tellzy-CH 6.25 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Tellzy-CH 6.25 Tablet can be taken with ramipril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking ramipril with Tellzy-CH 6.25 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Tellzy-CH 6.25 Tablet can be taken with ramipril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Tellzy-CH 6.25 Tablet:
Taking lisinopril with Tellzy-CH 6.25 Tablet may increase the levels of potassium in blood.
How to manage the interaction:
Although there is a possible interaction, Tellzy-CH 6.25 Tablet can be taken with lisinopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications.
Taking lisinopril with Tellzy-CH 6.25 Tablet may increase the levels of potassium in blood.
How to manage the interaction:
Although there is a possible interaction, Tellzy-CH 6.25 Tablet can be taken with lisinopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications.
TelmisartanPotassium acetate
Severe
How does the drug interact with Tellzy-CH 6.25 Tablet:
Co-administration of Potassium acetate can make Tellzy-CH 6.25 Tablet more likely to cause high levels of potassium in the blood.
How to manage the interaction:
Although taking Potassium acetate and Tellzy-CH 6.25 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Co-administration of Potassium acetate can make Tellzy-CH 6.25 Tablet more likely to cause high levels of potassium in the blood.
How to manage the interaction:
Although taking Potassium acetate and Tellzy-CH 6.25 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
TelmisartanPotassium citrate
Severe
How does the drug interact with Tellzy-CH 6.25 Tablet:
Taking Potassium citrate with Tellzy-CH 6.25 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Tellzy-CH 6.25 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Taking Potassium citrate with Tellzy-CH 6.25 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Tellzy-CH 6.25 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Severe
How does the drug interact with Tellzy-CH 6.25 Tablet:
Co-administration of Tellzy-CH 6.25 Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Tellzy-CH 6.25 Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
Co-administration of Tellzy-CH 6.25 Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Tellzy-CH 6.25 Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Tellzy-CH 6.25 Tablet:
Taking perindopril with Tellzy-CH 6.25 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Tellzy-CH 6.25 Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking perindopril with Tellzy-CH 6.25 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Tellzy-CH 6.25 Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Tellzy-CH 6.25 Tablet:
Taking quinapril with Tellzy-CH 6.25 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Tellzy-CH 6.25 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking quinapril with Tellzy-CH 6.25 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Tellzy-CH 6.25 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Drug-Food Interactions
CHLORTHALIDONE-6.25MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Drug-Food Interactions
Login/Sign Up
CHLORTHALIDONE-6.25MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Common Foods to Avoid:
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Tellzy-CH 6.25 Tablet along with potassium-containing salt substitutes or over-the-counter potassium supplements it may lead to high potassium levels in blood. Avoid high potassium rich food while taking Tellzy-CH 6.25 Tablet as it can possibly result in an interaction. However, consult a doctor if you experience weakness, irregular heartbeat, confusion and feelings of heaviness in the legs.
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Tellzy-CH 6.25 Tablet along with potassium-containing salt substitutes or over-the-counter potassium supplements it may lead to high potassium levels in blood. Avoid high potassium rich food while taking Tellzy-CH 6.25 Tablet as it can possibly result in an interaction. However, consult a doctor if you experience weakness, irregular heartbeat, confusion and feelings of heaviness in the legs.
Product Substitutes
शराब
असुरक्षित
आपको सलाह दी जाती है कि शराब का सेवन न करें और टेल्ज़ी-CH 6.25 टैबलेट 15's उनींदापन, चक्कर आना और लीवर खराब होने जैसे अप्रिय दुष्प्रभावों से बचने के लिए।
गर्भावस्था
असुरक्षित
टेल्ज़ी-CH 6.25 टैबलेट 15's गर्भावस्था के दौरान अनुशंसित नहीं है क्योंकि यह श्रेणी D गर्भावस्था की दवा है। यह दवा भ्रूण को नुकसान पहुंचा सकती है और अजन्मे बच्चे (भ्रूण) को प्रभावित कर सकती है।
स्तनपान
असुरक्षित
टेल्ज़ी-CH 6.25 टैबलेट 15's स्तन के दूध से गुजरने के लिए जाना जाता है, लेकिन बच्चे पर इसका प्रभाव ज्ञात नहीं है। इसलिए, स्तनपान कराने से पहले, अपने डॉक्टर को इसके बारे में बताएं। या तो आपको टेल्ज़ी-CH 6.25 टैबलेट 15's का उपयोग करने के लिए स्तनपान बंद करने की आवश्यकता है, या आपको टेल्ज़ी-CH 6.25 टैबलेट 15's लेना बंद करने की आवश्यकता है।
ड्राइविंग
असुरक्षित
सावधानी से गाड़ी चलाएँ, टेल्ज़ी-CH 6.25 टैबलेट 15's आमतौर पर उनींदापन का कारण बनता है और ड्राइविंग क्षमता को प्रभावित करता है।
जिगर
सावधानी
टेल्ज़ी-CH 6.25 टैबलेट 15's सावधानी के साथ लेना है, खासकर यदि आपको लीवर की बीमारी का इतिहास रहा है। आपके डॉक्टर को आपकी चिकित्सा स्थिति और उपचार के प्रति आपकी प्रतिक्रिया के आधार पर खुराक बदलनी होगी।
गुर्दा
असुरक्षित
पुरानी गुर्दे की बीमारी (गंभीर गुर्दे की हानि) वाले रोगियों में अनुशंसित नहीं है। गंभीर गुर्दे की हानि वाले रोगियों में सुरक्षा और प्रभावशीलता स्थापित नहीं की गई है।
बच्चे
सावधानी
बच्चों में टेल्ज़ी-CH 6.25 टैबलेट 15's की प्रभावकारिता और सुरक्षा स्थापित नहीं की गई है। यदि निर्धारित किया जाता है, तो यह सख्ती से चिकित्सा पर्यवेक्षण के अधीन होना चाहिए और केवल तभी जब लाभ नुकसान से अधिक हो।
Have a query?
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
